Weight loss drives much of the benefit, but the drugs also appear to act directly on liver inflammation
If not addressed, stomach paralysis may lead to malnutrition, dehydration, and blood sugar complications
Reduced Stability and PH-Dependent Activity of a Common Obesity-Linked PCSK1 Polymorphism, N221D. Endocrinology, vol
Potential side effects are not the only drawback with GLP-1 drugs
People who remain on treatment for five years maintain better glycemic control, lower body weight, and reduced cardiovascular risk compared with those who stop
135 Tirzepatide is developed by Eli Lilly and has proven to provide superior blood sugar control and significant weight loss, making it particularly valuable in the treatment of T2DM